Camlin Fine Sciences Limited

BSE:532834 Stock Report

Market Cap: ₹28.2b

Camlin Fine Sciences Past Earnings Performance

Past criteria checks 2/6

Camlin Fine Sciences's earnings have been declining at an average annual rate of -31.5%, while the Chemicals industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 7.7% per year. Camlin Fine Sciences's return on equity is 1.7%, and it has net margins of 1.1%.

Key information

-31.51%

Earnings growth rate

-35.23%

EPS growth rate

Chemicals Industry Growth17.68%
Revenue growth rate7.66%
Return on equity1.73%
Net Margin1.07%
Last Earnings Update30 Sep 2025

Recent past performance updates

Recent updates

Tariff Benefits And Safety Trends Will Boost US And Europe

Key Takeaways Plant restarts and easing exceptional expenses are set to improve margins, with structural growth driven by global demand for compliant, high-quality food additives. Favorable trade barriers and China+1 supply diversification position Camlin Fine Sciences for market share gains, margin expansion, and reduced dependence on legacy products.

Revenue & Expenses Breakdown

How Camlin Fine Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:532834 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2517,5171872,3860
30 Jun 2517,0928252,2620
31 Mar 2516,6656852,1290
31 Dec 2416,540-2,1552,4700
30 Sep 2416,064-2,2312,4060
30 Jun 2415,893-1,4232,3150
31 Mar 2414,5396511,9770
31 Dec 2316,381-81,9310
30 Sep 2316,4003501,8930
30 Jun 2317,1746741,8500
31 Mar 2316,8165771,8230
31 Dec 2216,4415811,7270
30 Sep 2216,3716281,7100
30 Jun 2214,6504421,6660
31 Mar 2214,1216501,5820
31 Dec 2113,4955981,5210
30 Sep 2112,6664651,4360
30 Jun 2112,1225791,3750
31 Mar 2111,8715101,3010
31 Dec 2011,5333941,3120
30 Sep 2011,2932911,2550
30 Jun 2010,9483021,2070
31 Mar 2010,4913031,1800
31 Dec 1910,2433491,1700
30 Sep 199,9182771,1390
30 Jun 199,7092211,1210
31 Mar 198,92261,0920
31 Dec 188,523-1391,0530
30 Sep 188,186-2221,0160
30 Jun 187,634-2779690
31 Mar 187,206-3389350
31 Dec 176,403-36786520
30 Sep 175,676-31184320
30 Jun 175,347-27582022
31 Mar 175,339-1288200
31 Dec 165,1499873721
30 Sep 165,01317464921
30 Jun 165,06323249621
31 Mar 164,89335856221
31 Dec 155,08344587925
30 Sep 155,23846390625
30 Jun 155,53155288325
31 Mar 155,58355051625

Quality Earnings: 532834 has high quality earnings.

Growing Profit Margin: 532834 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 532834's earnings have declined by 31.5% per year over the past 5 years.

Accelerating Growth: 532834 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 532834 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (10.1%).

Return on Equity

High ROE: 532834's Return on Equity (1.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/25 14:05
End of Day Share Price 2025/11/25 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Camlin Fine Sciences Limited is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ankur PeriwalAxis Capital Limited
Abhishek NavalgundCentrum Broking Limited
Satish KumarCGS International